NDC 72511-760 – Repatha
Evolocumab 140 mg/mL · Injection, Solution · Subcutaneous
Product NDC72511-760
Product details
- Brand name
- Repatha
- Generic name
- Evolocumab
- Labeler
- Amgen USA Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA125522
- Marketed since
- October 9, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- PCSK9 Inhibitor
Active ingredients
- Evolocumab 140 mg/mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 72511-760-02 | 2 SYRINGE in 1 CARTON (72511-760-02) / 1 mL in 1 SYRINGE (72511-760-01) | Oct 9, 2018 |
| 72511-760-91 sample | 1 SYRINGE in 1 CARTON (72511-760-91) / 1 mL in 1 SYRINGE | Jun 1, 2022 |